OneMedNet Corp (NASDAQ:ONMD) shares surged premarket after announcing a partnership with Palantir Technologies Inc. to advance healthcare AI and data analytics operations. The collaboration aims to unlock the $868 billion AI healthcare market by 2030 with secure, scalable solutions. Palantir’s AI Platform will connect with OneMedNet’s network, offering access to vast amounts of clinical data.

The partnership spans key therapeutic areas like oncology, cardiology, and rare diseases. Using Palantir’s AI Platform, OneMedNet plans to power its iRWD near real-time AI-enabled provider network. This platform will provide access to anonymized clinical data and advanced analytics for medical innovation acceleration. OneMedNet’s President and CEO, Aaron Green, expressed excitement about the breakthrough potential in clinical research and healthcare solutions.

ONMD shares were trading higher by 46.60% to $1.510 premarket. This partnership signals a significant step towards revolutionizing healthcare AI and data analytics, positioning both companies for groundbreaking advancements in the field. With access to a vast network of clinical data, the collaboration aims to drive innovation and accelerate the development of next-generation medical solutions.

Read more at Yahoo Finance: OneMedNet Teams Up With Palantir To Supercharge AI In Healthcare